Immediate Impact
10 from Science/Nature 73 standout
Citing Papers
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Works of Donal Gorman being referenced
Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes
2023
Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes
2023 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Donal Gorman | 227 | 222 | 108 | 201 | 24 | 879 | |
| H. Rochlitz | 168 | 180 | 64 | 325 | 17 | 813 | |
| Elena Giordano | 188 | 215 | 177 | 180 | 26 | 1.1k | |
| Isabelle Dumont | 109 | 235 | 91 | 209 | 52 | 958 | |
| Christine Brennan | 125 | 203 | 44 | 121 | 22 | 852 | |
| Carol A. Maggio | 409 | 172 | 152 | 480 | 14 | 1.1k | |
| Michael T. Pedrini | 299 | 300 | 46 | 299 | 22 | 1.0k | |
| Rosaria De Iasio | 371 | 142 | 94 | 206 | 22 | 938 | |
| Luciana C. Caperuto | 138 | 313 | 31 | 274 | 35 | 1.1k | |
| Chak Leung Au | 295 | 306 | 94 | 190 | 34 | 1.1k | |
| Wasaku Koyama | 245 | 255 | 42 | 429 | 26 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...